Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia. (2024)
Attributed to:
Importance of N-glycosylation at the Neuromuscular Junction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2024.02.09.579626
PubMed Identifier: 38405691
Publication URI: http://europepmc.org/abstract/MED/38405691
Type: Journal Article/Review
Parent Publication: bioRxiv : the preprint server for biology